{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:04:48Z","timestamp":1790906688594,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ccell.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T10:39:36Z","timestamp":1626950376000},"page":"1214-1226.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity"],"prefix":"10.1016","volume":"39","author":[{"given":"Joseph M.","family":"Gozgit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Vasbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Abo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiko","family":"Kunii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy G.","family":"Kuplast-Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Z.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Minissale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerren K.","family":"Swinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Wigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Majer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6199-1715","authenticated-orcid":false,"given":"Yue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-6295","authenticated-orcid":false,"given":"Mario","family":"Niepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacharenia A.","family":"Varsamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunaina P.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Rung","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. David","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-3564","authenticated-orcid":false,"given":"Ahmed S.A.","family":"Mady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Utley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-699X","authenticated-orcid":false,"given":"Patricia E.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Mitchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Richon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Keilhack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2021.06.018_bib2","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1038\/ncomms6166","article-title":"Inflammation-driven carcinogenesis is mediated through STING","volume":"5","author":"Ahn","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2021.06.018_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons alpha and beta in cancer: therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2021.06.018_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","article-title":"Interferons and their stimulated genes in the tumor microenvironment","volume":"41","author":"Cheon","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ccell.2021.06.018_bib6","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2021.06.018_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nchembio.2568","article-title":"Insights into the biogenesis, function, and regulation of ADP-ribosylation","volume":"14","author":"Cohen","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2021.06.018_bib9","doi-asserted-by":"crossref","first-page":"31782","DOI":"10.1038\/srep31782","article-title":"Increasing the performance of pooled CRISPR-Cas9 drop-out screening","volume":"6","author":"Cross","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2021.06.018_bib10","article-title":"Extracting biological insights from the project Achilles genome-scale CRISPR screens in cancer cell lines","author":"Dempster","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2021.06.018_bib11","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-dependent antitumor immunity in brca1-deficient ovarian cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2021.06.018_bib12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.3000","article-title":"A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors","volume":"39","author":"Falchook","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2021.06.018_bib13","unstructured":"Flood, B.. (2017). Tumor cell-intrinsic STING signaling and regulation of IFN-\u03b2 gene expression. Paper presented at: Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017)."},{"key":"10.1016\/j.ccell.2021.06.018_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12765","article-title":"STING pathway agonism as a cancer therapeutic","volume":"290","author":"Flood","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2021.06.018_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2021.06.018_bib16","first-page":"5450","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Commun"},{"key":"10.1016\/j.ccell.2021.06.018_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gluck","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib18","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1042\/BCJ20180347","article-title":"Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP\/ARTD14) catalytic activity","volume":"475","author":"Gomez","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.ccell.2021.06.018_bib19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2021.06.018_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.immuni.2015.01.012","article-title":"DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity","volume":"42","author":"Hartlova","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2021.06.018_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","article-title":"Catastrophic nuclear envelope collapse in cancer cell micronuclei","volume":"154","author":"Hatch","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2021.06.018_bib24","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.93.18.9730","article-title":"The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product","volume":"93","author":"Huang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2021.06.018_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib28","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1021\/jm5018237","article-title":"Niraparib: a poly(ADP-ribose) polymerase (PARP) inhibitor for the treatment of tumors with defective homologous recombination","volume":"58","author":"Jones","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2021.06.018_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/acschembio.7b00965","article-title":"CRISPR approaches to small molecule target identification","volume":"13","author":"Jost","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","article-title":"Robust rank aggregation for gene list integration and meta-analysis","volume":"4","author":"Kolde","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2021.06.018_bib31","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1093\/nar\/gkz1118","article-title":"STRIDE\u2014a fluorescence method for direct, specific in\u00a0situ detection of individual single- or double-strand DNA breaks in fixed cells","volume":"48","author":"Kordon","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2021.06.018_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2021.06.018_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2019.05.007","article-title":"Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation","volume":"167","author":"Lu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ccell.2021.06.018_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2021.06.018_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/nar\/gks1337","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation","volume":"41","author":"MacPherson","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2021.06.018_bib39","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.3390\/ijms15057939","article-title":"Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling","volume":"15","author":"MacPherson","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2021.06.018_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-editing enzyme ADAR1 controls innate immune responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2021.06.018_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cotox.2017.01.013","article-title":"AHR toxicity and signaling: role of TIPARP and ADP-ribosylation","volume":"2","author":"Matthews","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.ccell.2021.06.018_bib43","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2021.06.018_bib44","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.2147\/OTT.S139336","article-title":"Current status of poly(ADP-ribose) polymerase inhibitors and future directions","volume":"10","author":"Ohmoto","year":"2017","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.ccell.2021.06.018_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41577-018-0117-0","article-title":"DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer","volume":"19","author":"Paludan","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T\u00a0cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2021.06.018_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2021.06.018_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2021.06.018_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.ccell.2021.06.018_bib49","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.4049\/jimmunol.1200310","article-title":"Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback","volume":"189","author":"Pattison","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib50","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quintas-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2021.06.018_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/278451a0","article-title":"The beige mutation in the mouse selectively impairs natural killer cell function","volume":"278","author":"Roder","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2021.06.018_bib53","doi-asserted-by":"crossref","first-page":"17693","DOI":"10.1038\/s41598-017-18172-6","article-title":"Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance","volume":"7","author":"le Sage","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2021.06.018_bib55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","article-title":"PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness","volume":"79","author":"Shen","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2021.06.018_bib56","article-title":"Characterization of directed differentiation by high-throughput single-cell RNA-seq","author":"Soumillon","year":"2014","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2021.06.018_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41573-019-0043-2","article-title":"Pharmacological modulation of nucleic acid sensors\u2014therapeutic potential and persisting obstacles","volume":"18","author":"Vanpouille-Box","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2021.06.018_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acs.jmedchem.5b01498","volume":"59","author":"Wang","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2021.06.018_bib60","first-page":"1193","article-title":"Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy","volume":"53","author":"Wang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccell.2021.06.018_bib61","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.chembiol.2020.06.009","article-title":"In\u00a0vitro and cellular probes to study PARP enzyme target engagement","volume":"27","author":"Wigle","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ccell.2021.06.018_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2472555219883623","article-title":"Forced self-modification assays as a strategy to screen MonoPARP enzymes","volume":"25","author":"Wigle","year":"2020","journal-title":"SLAS Discov."},{"key":"10.1016\/j.ccell.2021.06.018_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni.3422","article-title":"Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense","volume":"17","author":"Yamada","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2021.06.018_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610821003408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610821003408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:06:50Z","timestamp":1761523610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610821003408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1535610821003408"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2021.06.018","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}